Judge Dismisses 1,000 Shingles Vaccine Claims Against Merck for Lack of Evidence December 8, 2022 By Andrew G. Simpson After four years of multidistrict litigation, a federal judge in Pennsylvania has dismissed 1,189 lawsuits claiming the Zostavax shingles vaccine...
Ruling on Purdue Pharma Bankruptcy and Opioid Settlement Delayed Until Next Week August 27, 2021 By Mike Spector and Maria Chutchian A U.S. judge said on Thursday he now anticipates a ruling on OxyContin maker Purdue Pharma LP’s bankruptcy reorganization plan...
West Virginia’s Billion-Dollar Trial Against Opioid Distributors Gets Underway May 3, 2021 The three largest U.S. drug distributors, who are accused of helping fuel the opioid crisis that has resulted in nearly...
U.S. Oversight Board Questions AstraZeneca’s COVID-19 Vaccine Data March 23, 2021 By Miyoung Kim and Caroline Copley AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a...
Investor Sues Drugmaker Astrazeneca Over Coronavirus Vaccine Testing Claims January 27, 2021 By Robert Burnson AstraZeneca PLC was sued by a pension fund on behalf of investors who it says suffered losses because of flaws...
Investor Suit Alleges Pharma Company Made False Claim of COVID-19 Vaccine March 18, 2020 By Andrew G. Simpson Pennsylvania-based Inovio Pharmaceuticals is the target of a planned class action lawsuit alleging it falsely claimed it has developed a...
Judge Cuts Johnson & Johnson Damages in Risperdal Case From $8 Billion to $6.8 Million January 21, 2020 By Jonathan Stempel A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson...
FDA Moving Quickly to Approve New Drugs. Is It Too Quickly? December 11, 2019 By Michelle Fay Cortez and Cristin Flanagan The U.S. is approving new drugs so fast that companies are now preparing for a green light months in advance...
After Avoiding Ohio Trial, Drug Firms Turn to Local Government Opioid Lawsuits October 22, 2019 By Kathy Gray Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid...
Settling Opioid Suits Probably Won’t End the Crisis: Viewpoint October 21, 2019 By Joe Nocera, Bloomberg Opinion Imagine you’re the chief executive officer of a large pharmaceutical corporation with an important drug that’s under attack. More than...